V11294A is a novel PDE4 inhibitor. A single oral 300 mg dose of V11294A administered to healthy volunteers results in plasma concentrations adequate to inhibit activation of inflammatory cells ex vivo, which persists for at least 24 h without any adverse reactions
Molecular Weight:
409.52
CAS Number:
[162278-10-6]
Formula:
C23H31N5O2
Target:
Others
T70362
* VAT and and shipping costs not included. Errors and price changes excepted
